• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于外显子包含的双功能反义寡核苷酸的设计。

Design of Bifunctional Antisense Oligonucleotides for Exon Inclusion.

机构信息

Genetic and Genomics Medicine Research and Teaching Department, Great Ormond Street Institute of Child Health, University College London, London, UK.

NIHR Great Ormond Street Hospital Biomedical Research Centre, London, UK.

出版信息

Methods Mol Biol. 2022;2434:53-62. doi: 10.1007/978-1-0716-2010-6_3.

DOI:10.1007/978-1-0716-2010-6_3
PMID:35213009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9703293/
Abstract

Bifunctional antisense oligonucleotide (AON) is a specially designed AON to regulate pre-messenger RNA (pre-mRNA) splicing of a target gene. It is composed of two domains. The antisense domain contains sequences complementary to the target gene. The tail domain includes RNA sequences that recruit RNA binding proteins which may act positively or negatively in pre-mRNA splicing. This approach can be designed as targeted oligonucleotide enhancers of splicing, named TOES, for exon inclusion; or as targeted oligonucleotide silencers of splicing, named TOSS, for exon skipping. Here, we provide detailed methods for the design of TOES for exon inclusion, using SMN2 exon 7 splicing as an example. A number of annealing sites and the tail sequences previously published are listed. We also present methodology of assessing the effects of TOES on exon inclusion in fibroblasts cultured from a SMA patient. The effects of TOES on SMN2 exon 7 splicing were validated at RNA level by PCR and quantitative real-time PCR, and at protein level by western blotting.

摘要

双功能反义寡核苷酸 (AON) 是一种专门设计的 AON,用于调节靶基因的前信使 RNA (pre-mRNA) 剪接。它由两个结构域组成。反义结构域包含与靶基因互补的序列。尾结构域包含招募 RNA 结合蛋白的 RNA 序列,这些蛋白可能在 pre-mRNA 剪接中发挥正或负作用。这种方法可以设计为靶向剪接的寡核苷酸增强子,称为 TOES,用于外显子包含;或设计为靶向剪接的寡核苷酸沉默子,称为 TOSS,用于外显子跳过。在这里,我们提供了设计用于外显子包含的 TOES 的详细方法,以 SMN2 外显子 7 剪接为例。列出了以前发表的一些退火位点和尾序列。我们还介绍了在从 SMA 患者培养的成纤维细胞中评估 TOES 对外显子包含的影响的方法。通过 PCR 和定量实时 PCR 在 RNA 水平,通过 Western blot 在蛋白质水平验证了 TOES 对 SMN2 外显子 7 剪接的影响。

相似文献

1
Design of Bifunctional Antisense Oligonucleotides for Exon Inclusion.用于外显子包含的双功能反义寡核苷酸的设计。
Methods Mol Biol. 2022;2434:53-62. doi: 10.1007/978-1-0716-2010-6_3.
2
Design principles for bifunctional targeted oligonucleotide enhancers of splicing.双功能靶向寡核苷酸剪接增强子的设计原则。
Nucleic Acids Res. 2011 Sep 1;39(16):7194-208. doi: 10.1093/nar/gkr152. Epub 2011 May 20.
3
Redirecting splicing with bifunctional oligonucleotides.用双功能寡核苷酸重定向剪接
Nucleic Acids Res. 2014 Apr;42(6):e40. doi: 10.1093/nar/gkt1287. Epub 2013 Dec 26.
4
Evolving concepts on human SMN pre-mRNA splicing.关于人类生存运动神经元前体信使核糖核酸剪接的不断演变的概念。
RNA Biol. 2007 Jan-Mar;4(1):7-10. doi: 10.4161/rna.4.1.4535. Epub 2007 Jun 4.
5
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts.脊髓性肌萎缩症患者成纤维细胞中剪接转换反义寡核苷酸诱导的外显子包含情况评估
J Vis Exp. 2018 May 11(135):57530. doi: 10.3791/57530.
6
Antisense Oligonucleotide Induction of the hnRNPA1b Isoform Affects Pre-mRNA Splicing of in SMA Type I Fibroblasts.反义寡核苷酸诱导 hnRNPA1b 异构体影响 SMA 型 I 成纤维细胞的前体 mRNA 剪接。
Int J Mol Sci. 2022 Apr 1;23(7):3937. doi: 10.3390/ijms23073937.
7
Designing Effective Antisense Oligonucleotides for Exon Skipping.设计用于外显子跳跃的有效反义寡核苷酸
Methods Mol Biol. 2018;1687:143-155. doi: 10.1007/978-1-4939-7374-3_10.
8
Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.抗肌萎缩蛋白基因中反义寡核苷酸诱导外显子跳跃的靶点选择
J Gene Med. 2003 Jun;5(6):518-27. doi: 10.1002/jgm.361.
9
Antisense oligonucleotide-mediated exon skipping of CHRNA1 pre-mRNA as potential therapy for Congenital Myasthenic Syndromes.反义寡核苷酸介导的CHRNA1前体mRNA外显子跳跃作为先天性肌无力综合征的潜在治疗方法。
Biochem Biophys Res Commun. 2015 Jun 5;461(3):481-6. doi: 10.1016/j.bbrc.2015.04.035. Epub 2015 Apr 16.
10
Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion.设计用于外显子跳跃和外显子包含的有效剪接转换反义寡核苷酸的技巧。
Methods Mol Biol. 2018;1828:79-90. doi: 10.1007/978-1-4939-8651-4_5.

引用本文的文献

1
RNA binding proteins (RBPs) on genetic stability and diseases.RNA结合蛋白(RBPs)与遗传稳定性及疾病
Glob Med Genet. 2024 Nov 30;12(1):100032. doi: 10.1016/j.gmg.2024.100032. eCollection 2025 Mar.
2
HNRNPH1 regulates the neuroprotective cold-shock protein RBM3 expression through poison exon exclusion.HNRNPH1 通过排除毒性外显子来调节神经保护冷休克蛋白 RBM3 的表达。
EMBO J. 2023 Jul 17;42(14):e113168. doi: 10.15252/embj.2022113168. Epub 2023 May 30.

本文引用的文献

1
Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy.戈洛迪森增加杜氏肌营养不良症患者的肌营养不良蛋白产量。
Neurology. 2020 May 26;94(21):e2270-e2282. doi: 10.1212/WNL.0000000000009233. Epub 2020 Mar 5.
2
The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy.第十种获批的寡核苷酸疗法:用于杜氏肌营养不良症的golodirsen。
Nucleic Acid Ther. 2020 Apr;30(2):67-70. doi: 10.1089/nat.2020.0845. Epub 2020 Feb 11.
3
Golodirsen: First Approval.高罗特西普:首个获批
Drugs. 2020 Feb;80(3):329-333. doi: 10.1007/s40265-020-01267-2.
4
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.依库珠单抗治疗晚发性脊髓性肌萎缩症的疗效观察:一项随机、双盲、安慰剂对照 3 期试验
N Engl J Med. 2018 Feb 15;378(7):625-635. doi: 10.1056/NEJMoa1710504.
5
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy.依库珠单抗治疗婴儿型脊髓性肌萎缩症的疗效观察
N Engl J Med. 2017 Nov 2;377(18):1723-1732. doi: 10.1056/NEJMoa1702752.
6
Nusinersen: First Global Approval.依洛硫酸酯酶β注射液:全球首次获批
Drugs. 2017 Mar;77(4):473-479. doi: 10.1007/s40265-017-0711-7.
7
Redirecting splicing with bifunctional oligonucleotides.用双功能寡核苷酸重定向剪接
Nucleic Acids Res. 2014 Apr;42(6):e40. doi: 10.1093/nar/gkt1287. Epub 2013 Dec 26.
8
Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy.改良反义寡核苷酸设计以抑制异常 SMN2 基因转录加工:迈向脊髓性肌萎缩症的治疗方法。
PLoS One. 2013 Apr 22;8(4):e62114. doi: 10.1371/journal.pone.0062114. Print 2013.
9
A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice.一种新型针对 ISS-N1 的吗啉代寡核苷酸可改善严重脊髓性肌萎缩症转基因小鼠的拯救效果。
Hum Gene Ther. 2013 Mar;24(3):331-42. doi: 10.1089/hum.2012.211. Epub 2013 Mar 6.
10
Bifunctional RNAs targeting the intronic splicing silencer N1 increase SMN levels and reduce disease severity in an animal model of spinal muscular atrophy.靶向内含子剪接沉默子 N1 的双功能 RNA 可提高运动神经元存活基因 1 水平并减轻脊髓性肌萎缩症动物模型的疾病严重程度。
Mol Ther. 2012 Jan;20(1):119-26. doi: 10.1038/mt.2011.232. Epub 2011 Oct 25.